Stay updated on S65487 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S65487 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S65487 Combo with Azacitidine in AML Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and geographic identifiers.SummaryDifference19%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check37 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
Stay in the know with updates to S65487 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S65487 Combo with Azacitidine in AML Clinical Trial page.